Search results for "Latin."

showing 10 items of 3698 documents

Detection and prevention of enhanced biological phosphorus removal deterioration caused by Zoogloea overabundance.

2008

A sequencing batch reactor was operated in the conventional anaerobic-aerobic mode for enhanced biological phosphorus removal using acetate as the sole substrate. Despite the nutrients concentrations in the influent being high enough to satisfy the biological requirements, Zoogloea ramigera managed to grow in the system until it had negative effects on the process performance. The excess of exocellular polymeric material produced by this microorganism contributed to a viscous bulking phenomenon and caused important settling problems. The examination of the sludge under the microscope was a valuable tool to diagnose the cause of the imbalance in the process. The strategy adopted to avoid the…

biologyWaste managementZoogloeaChemistryPhosphoruschemistry.chemical_elementSequencing batch reactorPhosphorusGeneral Medicinebiology.organism_classificationPhosphorus metabolismZoogloeaPolyphosphate-accumulating organismsEquipment Failure AnalysisEnhanced biological phosphorus removalBioreactorsBioreactorEnvironmental ChemistryZoogloea ramigeraEquipment FailureWaste Management and DisposalWater Science and TechnologyEnvironmental technology
researchProduct

CCDC 1562675: Experimental Crystal Structure Determination

2017

Related Article: György Szalóki, Vincent Croué, Vincent Carré, Frédéric Aubriet, Olivier Alévêque, Eric Levillain, Magali Allain, Juan Aragó, Enrique Ortí, Sébastien Goeb, Marc Sallé|2017|Angew.Chem.,Int.Ed.|56|16272|doi:10.1002/anie.201709483

bis(mu-44'4''4'''-{(2367-tetrakis(369-trioxadecoxy)anthracene-910-diylidene)bis[(2H-13-dithiole-45-diyl-2-ylidene)]}tetrapyridine)-octakis(35-dichloro-246-trifluorophenyl)-tetra-platinum acetonitrile solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 783768: Experimental Crystal Structure Determination

2011

Related Article: V.Blanco, M.D.Garcia, A.Terenzi, E.Pia, A.Fernandez-Mato, C.Peinador, J.M.Quintela|2010|Chem.-Eur.J.|16|12373|doi:10.1002/chem.201002051

bis(mu~2~-2-(4-(4-pyridylmethyl)phenyl)-27-diazapyrenium)-bis(ethylenediamine)-di-platinum(ii) hexakis(hexafluorophosphate) triphenylene clathrate acetonitrile solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1428884: Experimental Crystal Structure Determination

2015

Related Article: Juanzhu Yan, Haifeng Su, Huayan Yang, Sami Malola, Shuichao Lin, Hannu Häkkinen, and Nanfeng Zheng|2015|J.Am.Chem.Soc.|137|11880|doi:10.1021/jacs.5b07186

bis(tetraphenylphosphonium) octadecakis(mu-24-dichlorobenzenethiolato)-platinum-tetracosa-silver unknown solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcomes at a single academic centre.

2020

INTRODUCTION: Pancreatic cancer (PC), even in the absence of metastatic disease, has a dismal prognosis. One-third of them are borderline resectable (BRPC) or locally advanced unresectable PC (LAUPC) at diagnosis. There are limited prospective data supporting the best approach on these tumours. Neoadjuvant chemotherapy (ChT) is being increasingly used in this setting. METHODS: This is a retrospective series of consecutive patients staged as BRPC or LAUPC after discussion in the multidisciplinary board (MDB) at an academic centre. All received neoadjuvant ChT, followed by chemoradiation (ChRT) in some cases, and those achieving enough downstaging had a curative-intent surgery. Descriptive da…

borderline resectableCancer Researchmedicine.medical_specialtyFOLFIRINOXmedicine.medical_treatmentpancreatic cancerNeutropeniaAdenocarcinomalcsh:RC254-282Pancreatic cancerAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective Studies1506Neoadjuvant therapyRetrospective StudiesOriginal ResearchChemotherapybusiness.industrymedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslocally advanced unresectableNeoadjuvant TherapyOxaliplatinSurgeryIrinotecanPancreatic NeoplasmsFOLFIRINOXOncologyFluorouracilbusinessmedicine.drugESMO open
researchProduct

Detection of

2019

Circulating tumor DNA (ctDNA) has emerged as a non-invasive “liquid biopsy” for early breast cancer diagnosis. We evaluated the suitability of ctDNA analysis in the diagnosis of early breast cancer after mammography findings, comparing PIK3CA and TP53 mutations between tumor biopsies and pre-biopsy circulating DNA. Matched plasma and frozen fresh tissue biopsies from patients with Breast Imaging-Reporting and Data System (BIRADS) 4c/5 mammography findings and subsequent diagnosis of primary breast cancer were analyzed using NGS TruSeq Custom Amplicon Low Input Panel (Illumina) and plasma SafeSEQ (Sysmex Inostics). The same plasma and tumor mutations were observed in eight of 29 patients (27…

breast cancerliquid biopsymolecular profilingcirculating tumor DNA (ctDNA)Articleearly-stage cancerJournal of clinical medicine
researchProduct

Efficacy of four cleaning solutions for the decontamination of selected cytotoxic drugs on the different surfaces of an automated compounding system

2018

The automated aseptic preparation of ready-to-administer antineoplastic drug solutions with robotic systems reduces the risk of occupational exposure. However, the surfaces in the preparation area of the robot are to be cleaned by wiping with an appropriate cleaning solution. The aim of the study was to evaluate the cleaning efficacy of four cleaning solutions on four surface materials installed in the APOTECAchemo robot. Predefined amounts of cisplatin (Cis), 5-fluorouracil (5-FU), and cyclophosphamide (CP) were intentionally spread on test plates made of stainless steel, aluminium, polyoxymethylene, and polycarbonate just as installed in the robotic system APOTECAchemo. After drying, the …

business.industryDrug CompoundingAntineoplastic drugDetergentsPublic Health Environmental and Occupational HealthAntineoplastic AgentsRoboticsHuman decontaminationPharmacologyRobotic systemsCompoundingAntineoplastic DrugsMedicineFluorouracilAseptic processingOccupational exposureCisplatinPharmacy Service HospitalbusinessCyclophosphamideDecontaminationJournal of Occupational and Environmental Hygiene
researchProduct

Controlling of geosmin and 2‐methylisoborneol induced off‐flavours in recirculating aquaculture system farmed fish—A review

2018

business.industryFish farmingAquatic animalRecirculating aquaculture system04 agricultural and veterinary sciences010501 environmental sciencesAquatic ScienceBiology01 natural sciencesGeosminAquatic organismsFisherychemistry.chemical_compoundchemistryAquaculture040102 fisheries0401 agriculture forestry and fisheriesFish <Actinopterygii>2-Methylisoborneolbusiness0105 earth and related environmental sciencesAquaculture Research
researchProduct

Mechanisms of Autocrine and Paracrine Growth Control in Acute Myelogenous Leukemia

1990

Blast cells of a high proportion of patients with acute myelogenous leukemia (AML) proliferate in response to exogenous hematopoetic growth factors, both in vitro [9, 14, 26, 36, 48, 65] and in vivo [20]. Whereas leukemic colony-forming cells (L-CFCs) from most patients share their growth factor dependence with normal committed myeloid progenitor cells (CFU-GMs), some AML samples autonomously form colonies in agar and are therefore believed to bypass growth factor requirements [17, 42, 72]. Autocrine growth factor production has been identified as one mechanism used by AML blasts to supply various growth-promoting molecules. Moreover nontransformed accessory bone marrow cells have been show…

business.industryGrowth factormedicine.medical_treatmentmedicine.diseaseColony-stimulating factorMyelogenousLeukemiaParacrine signallingmedicine.anatomical_structureCytokinehemic and lymphatic diseasesImmunologymedicineCancer researchBone marrowAutocrine signallingbusiness
researchProduct

Hematopoietic Stem Cell Mobilization for Gene Therapy: The Combination of G-CSF+Plerixafor in Patients with Beta-Thalassemia Major Provides High Yiel…

2015

Abstract Hematopoietic stem cell engineering is a promising therapy to cure b-thalassemia, in particular for patients who lack a suitable BM donor for allogeneic transplantation. Since the engrafted gene-corrected stem cells will not have any selective advantage over the unmodified ones, the effectiveness of the therapy in this setting largely depends on the infusion of high numbers of gene-modified cells and on the conditioning regimen. The quality of the infused cells is also crucial for the clinical outcome and the duration of the therapeutic effect. HSPCs mobilization, particularly when G-CSF and plerixafor are used in combination, has been proved to be the optimal approach to harvest a…

business.industryPlerixaforImmunologyHematopoietic stem cellHematopoietic Stem Cell Mobilization Gene Therapy Beta-Thalassemia.Cell BiologyHematologyLeukapheresisCD38PharmacologyBiochemistryCXCR4Granulocyte colony-stimulating factorSettore BIO/18 - Geneticamedicine.anatomical_structureImmunologyMedicineStem cellbusinessHematopoietic Stem Cell Mobilizationmedicine.drug
researchProduct